Helicobacter pylori and cancer among adults in Uganda.
Data from Africa on infection with Helicobacter pylori (H. pylori) are sparse. Therefore, as part of an epidemiological study of cancer in Uganda, we investigated the prevalence and determinants of antibodies against H. pylori among 854 people with different cancer types and benign tumours. Patients...
| Main Authors: | , , , , , , , , , , , |
|---|---|
| Format: | Journal article |
| Language: | English |
| Published: |
2006
|
| _version_ | 1797106403936043008 |
|---|---|
| author | Newton, R Ziegler, J Casabonne, D Carpenter, L Gold, B Owens, M Beral, V Mbidde, E Parkin, D Wabinga, H Mbulaiteye, S Jaffe, H |
| author_facet | Newton, R Ziegler, J Casabonne, D Carpenter, L Gold, B Owens, M Beral, V Mbidde, E Parkin, D Wabinga, H Mbulaiteye, S Jaffe, H |
| author_sort | Newton, R |
| collection | OXFORD |
| description | Data from Africa on infection with Helicobacter pylori (H. pylori) are sparse. Therefore, as part of an epidemiological study of cancer in Uganda, we investigated the prevalence and determinants of antibodies against H. pylori among 854 people with different cancer types and benign tumours. Patients were recruited from hospitals in Kampala, Uganda, interviewed about various demographic and lifestyle factors and tested for antibodies against H. pylori. In all patients combined, excluding those with stomach cancer (which has been associated with H. pylori infection), the prevalence of antibodies was 87% (723/833) overall, but declined with increasing age (p = 0.02) and was lower among people who were HIV seropositive compared to seronegative (p < 0.001). Otherwise, there were few consistent epidemiological associations. Among those with stomach cancer, 18/21 (86%) had anti-H. pylori antibodies (odds ratio 0.8, 95% confidence intervals 0.2-2.9, p = 0.7; estimated using all other patients as controls, with adjustment for age, sex and HIV serostatus). No other cancer site or type was significantly associated with anti-H. pylori antibodies. The prevalence of H. pylori reported here is broadly in accord with results from other developing countries, although the determinants of infection and its' role in the aetiology of gastric cancer in Uganda remain unclear. |
| first_indexed | 2024-03-07T07:01:57Z |
| format | Journal article |
| id | oxford-uuid:ffc95bd5-5020-40f0-b348-1ce5f4ec375f |
| institution | University of Oxford |
| language | English |
| last_indexed | 2024-03-07T07:01:57Z |
| publishDate | 2006 |
| record_format | dspace |
| spelling | oxford-uuid:ffc95bd5-5020-40f0-b348-1ce5f4ec375f2022-03-27T13:47:43ZHelicobacter pylori and cancer among adults in Uganda.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:ffc95bd5-5020-40f0-b348-1ce5f4ec375fEnglishSymplectic Elements at Oxford2006Newton, RZiegler, JCasabonne, DCarpenter, LGold, BOwens, MBeral, VMbidde, EParkin, DWabinga, HMbulaiteye, SJaffe, HData from Africa on infection with Helicobacter pylori (H. pylori) are sparse. Therefore, as part of an epidemiological study of cancer in Uganda, we investigated the prevalence and determinants of antibodies against H. pylori among 854 people with different cancer types and benign tumours. Patients were recruited from hospitals in Kampala, Uganda, interviewed about various demographic and lifestyle factors and tested for antibodies against H. pylori. In all patients combined, excluding those with stomach cancer (which has been associated with H. pylori infection), the prevalence of antibodies was 87% (723/833) overall, but declined with increasing age (p = 0.02) and was lower among people who were HIV seropositive compared to seronegative (p < 0.001). Otherwise, there were few consistent epidemiological associations. Among those with stomach cancer, 18/21 (86%) had anti-H. pylori antibodies (odds ratio 0.8, 95% confidence intervals 0.2-2.9, p = 0.7; estimated using all other patients as controls, with adjustment for age, sex and HIV serostatus). No other cancer site or type was significantly associated with anti-H. pylori antibodies. The prevalence of H. pylori reported here is broadly in accord with results from other developing countries, although the determinants of infection and its' role in the aetiology of gastric cancer in Uganda remain unclear. |
| spellingShingle | Newton, R Ziegler, J Casabonne, D Carpenter, L Gold, B Owens, M Beral, V Mbidde, E Parkin, D Wabinga, H Mbulaiteye, S Jaffe, H Helicobacter pylori and cancer among adults in Uganda. |
| title | Helicobacter pylori and cancer among adults in Uganda. |
| title_full | Helicobacter pylori and cancer among adults in Uganda. |
| title_fullStr | Helicobacter pylori and cancer among adults in Uganda. |
| title_full_unstemmed | Helicobacter pylori and cancer among adults in Uganda. |
| title_short | Helicobacter pylori and cancer among adults in Uganda. |
| title_sort | helicobacter pylori and cancer among adults in uganda |
| work_keys_str_mv | AT newtonr helicobacterpyloriandcanceramongadultsinuganda AT zieglerj helicobacterpyloriandcanceramongadultsinuganda AT casabonned helicobacterpyloriandcanceramongadultsinuganda AT carpenterl helicobacterpyloriandcanceramongadultsinuganda AT goldb helicobacterpyloriandcanceramongadultsinuganda AT owensm helicobacterpyloriandcanceramongadultsinuganda AT beralv helicobacterpyloriandcanceramongadultsinuganda AT mbiddee helicobacterpyloriandcanceramongadultsinuganda AT parkind helicobacterpyloriandcanceramongadultsinuganda AT wabingah helicobacterpyloriandcanceramongadultsinuganda AT mbulaiteyes helicobacterpyloriandcanceramongadultsinuganda AT jaffeh helicobacterpyloriandcanceramongadultsinuganda |